• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Keys to the glaucoma code: Early assessment, diagnosis, and treatment

Article

Perhaps more valuable if less provocative than clues to the "Da Vinci Code," as set out in the bestselling thriller, are the keys to the glaucoma code, which could lead to improvements in assessment, diagnosis, and treatment.

New Orleans-Perhaps more valuable if less provocative than clues to the "Da Vinci Code," as set out in the bestselling thriller, are the keys to the glaucoma code, which could lead to improvements in assessment, diagnosis, and treatment.

Speakers at a Sunday evening CME session held at the Audubon Aquarium of the Americas addressed a range of crucial glaucoma issues, starting with a presentation on the glaucoma continuum by Robert N. Weinreb, MD, University of California, San Diego. Dr. Weinreb also served as program chairman and moderator.

Christopher A. Girkin, MD, MSPH, University of Alabama at Birmingham, spoke on the importance of early detection and diagnosis, while Davis S. Friedman, MD, MPH, explained global risk assessment and thresholds for treatment of ocular hypertension. Richard K. Parrish II, MD, University of Miami School of Medicine, described how comprehensive glaucoma therapy must move beyond IOPs.

The program was jointly sponsored by Ophthalmology Times and the New York Eye and Ear Infirmary and supported by an unrestricted educational grant from Pfizer Ophthalmics.

Related Videos
© 2024 MJH Life Sciences

All rights reserved.